BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31662324)

  • 1. Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.
    Chen G; Park D; Magis AT; Behera M; Ramalingam SS; Owonikoko TK; Sica GL; Ye K; Zhang C; Chen Z; Curran WJ; Deng X
    Cancer Res; 2019 Dec; 79(24):6126-6138. PubMed ID: 31662324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression.
    Le Grand M; Berges R; Pasquier E; Montero MP; Borge L; Carrier A; Vasseur S; Bourgarel V; Buric D; André N; Braguer D; Carré M
    Sci Rep; 2017 Mar; 7():45136. PubMed ID: 28332584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
    Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J
    Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deguelin suppresses non-small cell lung cancer by inhibiting EGFR signaling and promoting GSK3β/FBW7-mediated Mcl-1 destabilization.
    Gao F; Yu X; Li M; Zhou L; Liu W; Li W; Liu H
    Cell Death Dis; 2020 Feb; 11(2):143. PubMed ID: 32081857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer.
    Zhang F; Shen M; Yang L; Yang X; Tsai Y; Keng PC; Chen Y; Lee SO; Chen Y
    Cancer Biol Ther; 2017 Aug; 18(8):606-615. PubMed ID: 28686074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.
    Park D; Anisuzzaman ASM; Magis AT; Chen G; Xie M; Zhang G; Behera M; Sica GL; Ramalingam SS; Owonikoko TK; Deng X
    Theranostics; 2021; 11(17):8500-8516. PubMed ID: 34373755
    [No Abstract]   [Full Text] [Related]  

  • 7. MCL-1 gains occur with high frequency in lung adenocarcinoma and can be targeted therapeutically.
    Munkhbaatar E; Dietzen M; Agrawal D; Anton M; Jesinghaus M; Boxberg M; Pfarr N; Bidola P; Uhrig S; Höckendorf U; Meinhardt AL; Wahida A; Heid I; Braren R; Mishra R; Warth A; Muley T; Poh PSP; Wang X; Fröhling S; Steiger K; Slotta-Huspenina J; van Griensven M; Pfeiffer F; Lange S; Rad R; Spella M; Stathopoulos GT; Ruland J; Bassermann F; Weichert W; Strasser A; Branca C; Heikenwalder M; Swanton C; McGranahan N; Jost PJ
    Nat Commun; 2020 Sep; 11(1):4527. PubMed ID: 32913197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EGFR signaling defines Mcl⁻1 survival dependency in neuroblastoma.
    Nalluri S; Peirce SK; Tanos R; Abdella HA; Karmali D; Hogarty MD; Goldsmith KC
    Cancer Biol Ther; 2015; 16(2):276-86. PubMed ID: 25756510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Ibr-7 derivative of ibrutinib exhibits enhanced cytotoxicity against non-small cell lung cancer cells via targeting of mTORC1/S6 signaling.
    Zhang B; Wang L; Zhang Q; Yan Y; Jiang H; Hu R; Zhou X; Liu X; Feng J; Lin N
    Mol Oncol; 2019 Apr; 13(4):946-958. PubMed ID: 30663221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase cleavage of Mcl-1 impairs its anti-apoptotic activity and proteasomal degradation in non-small lung cancer cells.
    Wang T; Yang Z; Zhang Y; Zhang X; Wang L; Zhang S; Jia L
    Apoptosis; 2018 Jan; 23(1):54-64. PubMed ID: 29256070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenethyl isothiocyanate synergistically induces apoptosis with Gefitinib in non-small cell lung cancer cells via endoplasmic reticulum stress-mediated degradation of Mcl-1.
    Zhang Q; Chen M; Cao L; Ren Y; Guo X; Wu X; Xu K
    Mol Carcinog; 2020 Jun; 59(6):590-603. PubMed ID: 32189414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo.
    Meng J; Dai B; Fang B; Bekele BN; Bornmann WG; Sun D; Peng Z; Herbst RS; Papadimitrakopoulou V; Minna JD; Peyton M; Roth JA
    PLoS One; 2010 Nov; 5(11):e14124. PubMed ID: 21124782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.
    Cao X; Yap JL; Newell-Rogers MK; Peddaboina C; Jiang W; Papaconstantinou HT; Jupitor D; Rai A; Jung KY; Tubin RP; Yu W; Vanommeslaeghe K; Wilder PT; MacKerell AD; Fletcher S; Smythe RW
    Mol Cancer; 2013 May; 12(1):42. PubMed ID: 23680104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induction and AKT/NF-κB inactivation are associated with regroafenib-inhibited tumor progression in non-small cell lung cancer in vitro and in vivo.
    Weng MC; Li MH; Chung JG; Liu YC; Wu JY; Hsu FT; Wang HE
    Biomed Pharmacother; 2019 Aug; 116():109032. PubMed ID: 31163381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.
    Chen G; Magis AT; Xu K; Park D; Yu DS; Owonikoko TK; Sica GL; Satola SW; Ramalingam SS; Curran WJ; Doetsch PW; Deng X
    J Clin Invest; 2018 Jan; 128(1):500-516. PubMed ID: 29227281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lenvatinib Induces AKT/NF-κB Inactivation, Apoptosis Signal Transduction and Growth Inhibition of Non-small Cell Lung Cancer
    Liu YC; Hsu FT; Chung JG; Weng MC; Ting CY; Tsai CJ; Lan A; Wu JY; Lin CC; Lin SS
    Anticancer Res; 2021 Jun; 41(6):2867-2874. PubMed ID: 34083277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formononetin inhibits tumor growth by suppression of EGFR-Akt-Mcl-1 axis in non-small cell lung cancer.
    Yu X; Gao F; Li W; Zhou L; Liu W; Li M
    J Exp Clin Cancer Res; 2020 Apr; 39(1):62. PubMed ID: 32276600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleckstrin homology domain of Akt kinase: a proof of principle for highly specific and effective non-enzymatic anti-cancer target.
    Joh EH; Hollenbaugh JA; Kim B; Kim DH
    PLoS One; 2012; 7(11):e50424. PubMed ID: 23189201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.
    Zhu ZC; Liu JW; Yang C; Zhao M; Xiong ZQ
    Cell Death Dis; 2019 May; 10(6):395. PubMed ID: 31113936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L).
    Min KJ; Seo BR; Bae YC; Yoo YH; Kwon TK
    Cell Death Dis; 2014 Feb; 5(2):e1063. PubMed ID: 24556678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.